Bet-A 0.1% (Cream)
20 gm tube: ৳ 44.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Betamethasone valerate |
| Company | Acme laboratories ltd |
| Also available as |
Indications
- Eczema in children and adults including atopic
- Infantile and descoid eczema
- Prurigo nodularis
- Psoriasis (excluding wide spread plaque psoriasis)
- Neurodermatoses including lichen simplex and lichen planus
- Seborrhoic dermatitis
- Contact sensitivity reaction
- Discoid lupus erythematoses and may be used as adjunct to systemic steroid therapy in generalized erythroderma
Pharmacology
- Synthetic adrenocorticosteroid
- Anti-inflammatory
- Antipruritic
- Vasoconstrictive
- Glucocorticoid in nature
- Analog of prednisolone
- Percutaneous absorption from the skin
- Occlusive dressings increase percutaneous absorption
Dosage & Administration
- Apply sparingly to the affected area two or three times daily until improvement occurs, then twice daily or less
- Usual maximum duration of therapy is three weeks
Interaction
- No significant drug interactions reported
Contraindications
- Hypersensitivity to any of the ingredients in the preparation
- Rosaceae & acne vulgaris
- Perioral dermatitis, perianal & genital pruritis
- Viral infections of the skin, e.g. herpes simplex & chicken pox
- Primary infected skin lesions caused by fungi or bacteria
- Dermatoses in children under one year of age
Side Effects
- Dryness
- Itching
- Burning
- Skin thinning
- Local irritation
- Features of hypercorticolism
- Telangiectasia
- Striae
- Skin atrophy
- Hypertrichosis
- Change in pigmentation
- Secondary infection
- Perioral dermatitis
- Allergic contact dermatitis
- Maceration of the skin
- Acneform eruption
- Exacerbation of symptoms
Pregnancy & Lactation
- Should not be used extensively in pregnancy
Precautions & Warnings
- Usually well tolerated but if signs of hypersensitivity appear, application should be stopped
- Long term continuous topical therapy should be avoided where possible, particularly in children as adrenal suppression may occur even without occlusion
- When extensive areas are treated, sufficient systemic absorption may occur to produce symptoms of hypercortisolism
- Atrophic changes after prolonged treatment
- Care needed to ensure that the preparation does not enter the eye if applied to the eyelids
- Withdrawal of topical corticosteroid therapy if any spread of the infection occurs
Therapeutic Class
- Corticosteroid
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children